Project Grant HT94252310111
Award Date 7/1/23
Completion Date 6/30/24
Dollars Obligated $317K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
- This $1,847,457.00 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research conducted by Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative and impactful studies across various medical domains, including cancer, neuroscience, infectious...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,671,258.00 to Yale University to conduct research on "ENGINEERING NEURONAL-SPECIFIC THERAPEUTIC MRNA TO TREAT RETT SYNDROME." The award period runs from December 15, 2024 to December 14, 2026. The research project aims to develop innovative mRNA-based therapeutic approaches to treat Rett syndrome, a rare neurological disorder, by...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The U.S. Defense Health Agency awarded a $465,568 Project Grant to The Johns Hopkins University to support research on "The Role of Epitranscriptomic Modulators in Response to Bipolar Androgen Therapy." This grant is part of the agency's Military Medical Research and Development program (CFDA 12.420), which funds biomedical research to transform healthcare for military personnel, veterans, and the broader public. The project aims to investigate medical solutions for the battlefield and...
- The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
- The U.S. Defense Health Agency awarded a $777,659 Project Grant to the Children's Research Institute in Washington, DC under the Military Medical Research and Development program (CFDA 12.420). The grant funding, which covers the period from August 1, 2025 to July 31, 2028, will support the institute's research on the use of pro-resolution and restorative pharmacology approaches for the treatment of Duchenne muscular dystrophy (DMD). As a non-profit pediatric research organization, the...
- The University of Rochester was awarded a $1,173,575 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Anticodon-Edited (ACE) tRNA Treatment of Nonsense-Mediated Duchenne Muscular Dystrophy". The award is for the period of August 1, 2025 to July 31, 2029. The Military Medical Research and Development program supports advanced biomedical research initiatives that aim to transform healthcare for military...
- The U.S. Defense Health Agency awarded a $1,675,000.00 Project Grant to Yale University to support the "DRUG DISCOVERY FOR DYSTONIA AND FRONTOTEMPORAL DEGENERATION" research project. This award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the general public. The project period runs from August 15, 2025 to August 14, 2029 and will...
- The Defense Health Agency awarded a $783,023 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "A PRECISION-MEDICINE APPROACH TO TARGETING ACQUIRED THERAPEUTIC RESISTANCE IN RTK-MUTATED NSCLC" over a 3-year period from June 1, 2025 to May 31, 2028. The Military Medical Research and Development program supports advanced...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...